CCID
Carlyle Credit Income Fund
$25.12
+0.32%
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
May 19, 2026
SEC
{
"summary": "Carlyle Credit Income Fund (CCID) reported Q2 2026 results with total investment income of $5.54M, well
8-K — Impact 5/10
May 15, 2026
SEC
Carlyle Credit Income Fund disclosed its unaudited net asset value per common share as of April 30, 2026, of $3.41 via a
8-K — Impact 3/10
Apr 15, 2026
SEC
Carlyle Credit Income Fund disclosed its unaudited net asset value (NAV) per common share of $3.34 as of March 31, 2026.
8-K — Impact 3/10
Analyst Ratings
2Strong Buy
6Buy
2Hold
0Sell
0Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 3.7/10.
NEUTRAL
8-K
5/10
{
"summary": "Carlyle Credit Income Fund (CCID) reported Q2 2026 results with total investment inc
May 19, 2026
NEUTRAL
8-K
3/10
Carlyle Credit Income Fund disclosed its unaudited net asset value per common share as of April 30,
May 15, 2026
NEUTRAL
8-K
3/10
Carlyle Credit Income Fund disclosed its unaudited net asset value (NAV) per common share of $3.34 a
Apr 15, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 80% buy across 10 analysts — 2 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -27.0% | — |
| Current FY 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -28.6% | — |
| Next FY 2027-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 12.0% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 6 | 2 | 0 | 0 | 80% | |
| May 1, 2026 | 2 | 6 | 2 | 0 | 0 | 80% | |
| Apr 1, 2026 | 2 | 6 | 2 | 0 | 0 | 80% | |
| Mar 1, 2026 | 2 | 6 | 2 | 0 | 0 | 80% | |
| Feb 1, 2026 | 2 | 6 | 2 | 0 | 0 | 80% | |
| Jan 1, 2026 | 2 | 6 | 2 | 0 | 0 | 80% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.